Search
PRIMARY HEALTH CARE LIMITED (PRY)

PRIMARY HEALTH CARE LIMITED (PRY)

  Print

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Primary Health Care Limited
Stock Code: PRY
Website: www.primaryhealthcare.com.au
GICS Sub-Industry: Health Care Distributors
Market Cap ($M): 1,506
Equiv. Shares (M): 500

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 3.010 $ 2.990 $ 3.060 $ 2.960 $ 2.980 919,846 $ 0.030  1.007 %

Current Broker Consensus Recommendation more
Recommendation: Hold
Recommendation Date: 19th Jan 2012
12 Month Target Price (average): $3.459
Brokers Surveyed: 8

Company Overview

Business Description:
Primary Health Care Limited (PRY) is a service company to medical and allied health professionals offering a range of medical and related services in its network of medial centres and pathology centres across Australia. PRY is also a provider of healthcare technology solutions to medical practitioners, medical practices and hospitals.

Strategy Analysis:
PRY's strategy is to build scale through integration. This provides extra processing volume in its pathology laboratories which translates to a lower unit cost of testing. Scale will also enable PRY to negotiate more favourable buying terms for consumables. The integrated company will have a larger breadth of medical centres which PRY management has experience in micro managing to extract and enhance greater economic returns. Primary Health Care reported NPAT down 40.7% to $78.29m for the year ended 30 June 2011. Revenues from ordinary activities were $1.32bn, up 2% from last year. Diluted EPS was 15.8 cents compared to 27.7 cents last year. Net operating cash flow was $160.41m compared to $225.04m last year. The final dividend declared was 5 cents, taking the full year dividend to 8 cents compared with 25 cents last year. Looking ahead, the company is well positioned to be able to leverage off its extensive footprint and low cost structure base to achieve EBITDA and margin growth in each of its divisions in FY2012, as well as provide payers with better outcomes for their expenditure.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2013  F 136.2 27.5 11.3 10.9 22.0 7.3 100.0
2012  F 122.4 24.7 19.0 12.2 17.0 5.6 100.0
2011  A 102.9 20.8 -25.1 16.5 8.0 2.3 100.0
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F
Primary Health Care (PRY) $1,491 M -0.2444 0.1744 0.1375 14.2379 12.1237 10.6581 0.0268 0.0489 0.0662
Sonic Healthcare (SHL) $4,430 M 0.0066 0.0928 0.0697 15.0464 13.7680 12.8711 0.0519 0.0558 0.0593
Sigma Pharma. (SIP) $695 M -- -- 0.0662 -- 13.0243 12.2153 0.2542 0.0508 0.0508

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
PRY 0.42 13.0 0.60 0.84 1.14
Market 0.80 12.5 1.38 1.16 1.88
Sector 0.71 16.0 1.48 1.26 1.45

Directors
Name Position Start Date
Mr Robert (Rob) A Ferguson Chairman 01 July 2009
Mr Andrew Duff Company Secretary 07 October 2011
Dr Edmund Gregory Thomas Bateman Managing Director 31 October 1994
Mr John David Crawford Non-Executive Director 03 July 1998
Mr Brian Francis Ball Non-Executive Director 02 November 1994
Mr Terence Noel Smith Non-Executive Director 21 April 2008
Mr Paul Jones Non-Executive Director 26 November 2010
Dr Errol Katz Non-Executive Director 26 November 2010

Management
Name Position
John Frost Chief Executive Officer Ã?? Health Technology
Matthew Bardsley Chief Information Officer
James Bateman Chief Operating Officer & General Manager Ã?? Pathology
Yvette Cachia-Woodland Company Secretary
Carl Adams General Manager Ã?? Diagnostic Imaging
Henry Bateman General Manager Ã?? Medical Centres

Substantial Shareholders
Holding Name
30,223,421 (6.10%) National Australia Bank Limited
31,001,441 (6.20%) BNP Paribas Investment Partners (Australia) Limited
51,092,672 (10.30%) Schroder Investment Management Australia Limited
45,372,191 (9.10%) Caledonia Investments Limited
39,310,941 (7.90%) E Bateman and related entities
52,761,000 (10.60%) Harris Associates L P
51,522,859 (10.40%) Maple Brown Abbott Limited
24,944,978 (5.00%) Dimensional Fund Advisors LP

Calendar of Events
Date Event
17 September 2012 Report (Annual)
20 August 2012 Report (Prelim)
24 February 2012 Report (Interim)
Search for Managed Funds, Superannuation Funds and Retirement Funds Find a Managed Fund Reduce your fees and save money on your Managed Funds with our 100% Entry Fee Rebate 100% Entry Fee Rebate

Login
Email
Password
     Log me in automatically in future
Forgotten password? | Secure Login | Terms & Conditions
Free Membership

Membership benefits...

  • 100% entry fee rebates
  • Cash back on your managed fund investments with our innovative TrailCap™ program
  • Independent research on...
    • over 1,000 managed funds
    • over 300 ASX-listed Companies
    • top performing suburbs/postcodes
  • Access to IPOs/floats & other investment offers
  • Superior investment tools...
    • Portfolio manager
    • Watchlists
    • Alerts
  • Regular investment e-newsletter

Advertisement

Portfolio / Watchlist

Start a new portfolio / view your existing portfolio.
Track all your assets and manage your investments easily.

Trade Shares Online from $19.95^

eNewsletter

Keep up to date with new investments and important news - subscribe to our FREE weekly eNewsletters. Sign up now!

Free Guides

Financing your Investment Property

An educational booklet to help you learn the language of residential property financing with an introduction on how the tax system can help improve your cashflow.

More details...


News

Call to block Rinehart's board bid

The Age 3/02/2012 | HIGH-PROFILE director Geoffrey Cousins has called on major shareholders to block Gina Rinehart from gaining a board seat at Fairfax Media.

Call to block Rinehart's board bid

The Age 3/02/2012 | HIGH-PROFILE director Geoffrey Cousins has called on major shareholders to block Gina Rinehart from gaining a board seat at Fairfax Media.

Fairfax urged to beware boardroom influence

Sydney Morning Herald 3/02/2012 | THE Telstra director Geoffrey Cousins has called on large shareholders in Fairfax Media to block Gina Rinehart from gaining a board seat.

Call to block Rinehart's board bid

The Age 3/02/2012 | Geoffrey Cousins calls on major shareholders to block Gina Rinehart from gaining a board seat at Fairfax Media.

PMP lowers guidance

Sydney Morning Herald 3/02/2012 | The publisher and direct marketer PMP has cut its earnings guidance and implemented further restructuring because of poor trading conditions and weaker printing orders. The news sent shares to a two-year low, down 4?, or 8.3 per cent, at 44?. Print markets in both Australia and New Zealand have suffered with existing customers using the services less, and intense competition for new contracts resulting in lower margins. Earnings before interest and tax, and before significant items, are now ...

Hedge funds give big to 'Wall Street candidate'

The Age 2/02/2012 | Donor records reveal Romney campaign heavily backed by hedge fund managers.

More...


Sponsored Links

More from our network...